A new drug, afatinib, buys more time for lung cancer patients


The speakers at the regional press conference, (from left) Prof Zhang, Prof Park and Boehringer Ingelheim International Therapeutic Area Head of Oncology and vice-president Dr Gerd Stehle, taking questions from the media after their presentations. — Boehringer Ingelheim

When you are dying, every moment matters.

Even more so when it is from a disease like cancer, which can strike you when you think you still have many years of living left.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Others Also Read